Serum Institute of India CEO Adar Poonawalla met Home Minister Amit Shah for 30 minutes in Parliament on Friday. He praised the government and Prime Minister Narendra Modi for supporting the government.
Serum Institute of India (SII) CEO Adar Poonawalla said he is hopeful that Covovax, another Covid-19 vaccine being made by SII, will be launched in October for adults and be ready for children by the first quarter of 2022.
Adar Poonawalla thanked the government for its support to Serum Institute. “We are very thankful to the government and Prime Minister Narendra Modi for their support for improving and helping our industry to scale up vaccine manufacturing.”
Adar Poonawalla added that his company is always trying to expand its Covishield production capacity to meet the demand. Poonawalla met Home Minister Amit Shah in Parliament and the meeting lasted for 30 minutes.
When asked about vaccines for kids, he said: “The Covovax vaccine for kids will be launched in the first quarter of the next year, most likely in January-February.”
The Serum Institute CEO said that he is hopeful that Covovax will be launched for adults in October. depending on DCGI approvals
While speaking on production capacity of Covishield, Adar Poonawalla said the present capacity of Covishield is 130 million doses per month and he will try to increase it further.
Earlier in the day, Poonawalla also met Health Minister Mansukh Mandaviya.
The minister tweeted that he had a productive discussion on the supply of the Covishield vaccine with Poonawalla.
— Mansukh Mandaviya (@mansukhmandviya) August 6, 2021
Last month, an expert panel of India’s Central Drug Authority recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, official sources had earlier said.